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Toxicity of organometal halide 
perovskite solar cells
Aslihan Babayigit, Anitha Ethirajan, Marc Muller and Bert Conings
In the last few years, the advent of metal halide perovskite solar cells has revolutionized the prospects 
of next-generation photovoltaics. As this technology is maturing at an exceptional rate, research on its 
environmental impact is becoming increasingly relevant.
Perovskites are a class of crystalline compounds described by the generic chemical formula ABX3. Within this 
family, organometal halide perovskites 
(OHPs, with A=CH3NH3+, HC(NH2)2+ 
and/or Cs+; B=Pb and/or Sn; X=I and/or 
Br) have garnered much interest as efficient 
light harvesters, but also in applications 
such as light-emitting diodes, lasers and 
photodetectors, in view of their favourable 
intrinsic properties, such as ambipolarity, 
high charge-carrier mobilities, high 
diffusion lengths and high absorption 
coefficients1. Brisk and impressive 
achievements have brought perovskite solar 
cells to a level near silicon photovoltaics in 
terms of efficiency (at least on a laboratory 
scale)2, yet an important downside of these 
materials in their current form is that they 
contain heavy metals. The photovoltaic 
community is very much aware of the 
toxicity issues associated with the Pb content 
of highly performing perovskite solar 
cells, and of the strain this imposes on the 
public perception and acceptance of the 
technology3–6. Sn is being proposed as a 
more environmentally friendly alternative 
to Pb, yet it can likewise induce detrimental 
environmental and health effects7,8. Even 
though the metal content per square metre 
of a solar panel is only a few hundred 
milligrams, the potential occupational and 
non-occupational exposure associated 
with the large-scale implementation of the 
technology should be treated with caution. 
In addition, upon moderate exposure to 
external stimuli (such as humidity, oxygen, 
elevated temperature or a combination 
of these factors) these perovskites tend to 
degrade into harmful compounds carrying 
heavy metals, which may readily leach into 
the environment as a result of the structural 
failure of a photovoltaic module9–11. Based 
on these concerns, there is an acute need 
to assess the impact of the widespread 
application of perovskite solar technology 
on the environment as well as on human 
and animal health. Until a clear consensus 
on this issue is reached — or an alternative 
non-toxic and equally performing perovskite 
compound is found — the safe deployment 
of this technology relies entirely on 
adopting precautionary measures against 
contamination at each stage of the device’s 
life, from fabrication to disposal/recycling.
Revisiting the CdTe debate
The concerns raised on the large-scale use 
of perovskite photovoltaics in view of the 
presence of heavy metals are reminiscent 
of the debate on cadmium telluride (CdTe) 
solar cells, whose efficiency became 
industrially relevant in the 1990s. In 
parallel with the rising interest towards the 
performance of this technology, awareness 
of the toxicity associated with Cd (and to a 
lesser extent Te) also grew in the scientific 
community12. The inherent toxicity of 
CdTe was initially assessed by extrapolating 
data from other Cd compounds (the so-
called read-across approach), yet it later 
appeared evident that this method leads 
to incorrect conclusions and to a large 
uncertainty in the evaluation of toxicity13. 
An important aspect neglected in practising 
read-across is that the hazard associated 
to different compounds deriving from 
the same elements strongly depends on 
their solubility. CdTe is a thermally and 
chemically very stable compound with a 
low solubility constant, Ksp, of 10–34 and, 
accordingly, its toxicity was revealed to be 
extremely low (particularly when compared 
to pure Cd and Te) once experiments not 
flawed by the read-across method were 
performed13. In contrast, the OHPs now used 
in photovoltaics are very unstable. Having 
a Ksp up to 29 orders of magnitude higher 
compared to CdTe, they can easily degrade 
to Pb or Sn compounds, thus significantly 
increasing their potential bioavailability14 
and their hazard for animal and human 
health, as confirmed by recent toxicity tests 
[Au:OK?] (see below [Au: please could 
you be more specific? E.g. a section/
Figure/Box])8,15. In order to fully evaluate 
such risks, specific toxicity assessments of 
those Pb- and Sn-based compounds that 
are relevant to the fabrication, degradation 
and decommissioning of these solar cells 
are necessary.
It is important to mention that, even 
though the actual toxicological hazard 
presented by CdTe is very low, rigorous 
industrial hygiene programmes have been 
implemented to protect workers’ health 
in manufacturing facilities16. Moreover, 
cost-effective and environmentally friendly 
recycling programs have been put in 
place, certainly contributing to the public 
acceptance of CdTe-based solar cells. 
For instance, the company First Solar is 
committed to recycling every CdTe module 
they have produced once it reaches the end 
of its functional lifetime17. Considering 
the prospect of a degree of toxicity 
that exceeds that of CdTe, even stricter 
measures should be taken in terms of safe 
handling during fabrication and recycling if 
perovskite technology is to mature towards 
large-scale implementation.
Kinetics of Pb and Sn intoxication
Here, a summary is provided of how 
Pb and Sn from OHPs could enter the 
human body and how these elements are 
processed. In case of Pb, the contents of 
this section are condensed into a scheme 
(Fig. 1) for clarity. No scheme is reported 
for Sn, as the data available in the literature 
are currently not sufficient to provide a 
comprehensive picture.
Upon accidental contact with Pb-
containing chemicals, three routes of intake 
need to be considered: gastrointestinal, 
respiratory and dermal uptake3,18. In 
general, when Pb compounds enter the 
body, their kinetics of metabolization fit a 
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so-called three-compartment model3,19,20 
(Fig. 1). Regardless of the mode of intake, 
blood (compartment one) transports the 
Pb compounds throughout the body to 
soft tissues (liver, kidney, nervous tissue; 
compartment two). Eventually, the skeleton 
is the major depository for Pb in the body 
(compartment three), with a total body 
burden of 90% and long half-life of 20 to 
30 years (compared to only a few weeks 
in the former compartments)19–21. Within 
all compartments, Pb ions cause damage 
through mimicry of essential elements 
such as Ca, Zn, and Fe21. In soft tissues, this 
results in impaired functionality of enzymes 
and receptors, whereas in blood it interferes 
with haem activity. During the early stages 
of exposure, Pb is only loosely deposited in 
the bones, hence some equilibration between 
Pb contained in the skeleton and in the 
blood does occur. However, upon prolonged 
continuous exposure Pb gradually fixates 
[Au: ‘attaches’ or ‘adheres’?] to the bones 
as insoluble lead phosphate. Pb is finally 
evacuated by the excretion mechanisms of 
the body, including through breast milk21. 
This represents a major risk for breastfed 
infants, who are more susceptible to heavy 
metal intoxication during the early stages 
of development22.
The toxicity of Sn from perovskites 
is rather complex compared to its Pb 
counterpart7. Due to the low redox potential 
(–0.15V) of Sn(II)/ [Au:OK to replace with 
‘and’? ‘/’ is slightly ambiguous.] Sn(IV) 
and the reducing character of Sn(II), rapid 
oxidation to more stable Sn(IV) occurs in 
ambient atmosphere. This reaction is further 
accelerated in aqueous environments and 
leads to the formation of hydroiodic acid as 
an acidic by-product8. Synthesis of Sn-based 
perovskites in laboratories typically occurs 
in a low-oxygen and dry environment, hence 
conversion to Sn(IV) in these conditions is 
slowed down. As a consequence, operators 
may be exposed to both Sn(IV) and 
unconverted Sn(II). This is an important 
factor because the difference in oxidation 
state has been proven to influence the net 
gastrointestinal absorption of Sn, and both 
oxidation states are not readily interconverted 
during transport through the body23,24. For 
chronic exposure, the oral absorption of 
Sn(II) is inversely proportional to the dose of 
administration (within certain boundaries), 
whereas it does not exceed 5% (a value much 
lower than for the Pb counterpart) during 
shorter timeframes23,25. In comparison, the 
acute oral absorption of Sn(IV) is below 1%23.
Upon ingestion of Sn compounds, 
some inhalation might also occur. Organic 
compounds can pass easily from the 
respiratory system to the bloodstream due 
to their solubility in fat, whereas inorganic 
Sn compounds are more bound to pass 
[Au: ‘likely to pass’? please clarify ‘more 
bound to pass’] when sufficiently small in 
diameter and water-soluble26. So far, data on 
the average portion of uptake via this route 
are lacking but, according to physiologically 
based pharmacokinetic (PBPK) modelling, 
70% of inhaled inorganic Sn compounds that 
are small enough to be inhaled at the level of 
the alveoli can be transported to the blood, 
from where they are further distributed27. 
No data are available on the absorption 
through dermal contact either, although 
reduced penetration is expected given the 
low water- and fat-solubility of inorganic Sn 
compounds associated with perovskites. As 
with Pb, the absorbed Sn is distributed via 
systemic transport. Most researchers agree 
that the skeletal site is a major depository 
for Sn23,28,29 but its fate in soft tissues is still 
unclear7,29. This holds true for the passage 
of Sn compounds through the blood–brain 
barrier as well7,23. According to the PBPK 
model, the following rough estimation 
of distribution can be given: from the 
maximum amount of Sn absorbed (5%), 50% 
is distributed to excreta (specific route not 
mentioned), 35% is deposited in bone and 
15% is uniformly distributed to remaining 
soft tissues30. Moreover, 95% of the ingested 
Sn is immediately removed from the body 
via the faeces, and the remaining 5% is 







































Figure 1 | Schematic overview of absorption, distribution and excretion of Pb compounds in the human body, compiled from references 3,4,18–21. For each route of 
intake, a percentage indicates the overall amount that can be absorbed. Pb not absorbed upon gastrointestinal intake leaves the body via the faeces (as indicated); 
Pb not absorbed by respiratory or dermal routes is assumed to have left the body directly by exhalation or to have lost contact through natural body movement, 
respectively (not indicated in the figure). Pb resides in all of the three compartments with a certain organ-specific retention time, after which it is excreted from 
the body. [Au: ‘Ksp in fat and H2O’ and Gastic acid Ksp’ have been deleted as their meaning was unclear, OK? If not, please provide more details.] 
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eliminated within 400 days30. Similarly to 
Pb, Sn(II) will interfere on a molecular 
level by mimicry of other divalent elements 
such as Ca, Fe, Zn but also Cu. Molecular 
deregulation has also been observed for 
Sn(IV), although to a much lesser extent.
Thresholds, symptoms and treatment. 
For both Sn and Pb exposure, various 
toxicological thresholds have been indicated 
[Au: introduced/discussed?] over the past 
decades. In 2003, a maximum blood Pb level 
(BLL) of 5 μg/dl was imposed by the World 
Health Organization (WHO)5. Technically 
speaking, this is commensurate with an acute 
intake of only 2.5 mg of PbI2 via ingestion 
or 0.5 mg via inhalation. This tolerance was 
however revoked in 2010 after the discovery 
of decreased intelligence and behavioural 
difficulties in children exposed to even 
lower values6. Neurological deficiencies, 
however, can also occur in adults, either 
due to chronic exposure or to a high acute 
uptake3–6,19,20,22,31. For these cases it has 
also firmly been proven that genotoxicity, 
carcinogenicity and reproductive defects 
can occur along with renal and hepatic 
dysfunction3–6. Nausea, vomiting, abdominal 
pain along with headaches, seizures and 
muscle weakness are instead symptoms 
signalling moderately acute toxicity3–6. In 
the case of Sn, a daily tolerable intake of 
2 mg/kg body weight was established by The 
Joint Expert Committee on Food Additives 
(JECFA) from the Food and Agriculture 
Organization of the United Nations (FAO) 
and WHO in 200132. Yet, JECFA concluded 
in 2005 that the available data so far were 
inadequate to establish an acute reference 
dose for inorganic Sn, as it was found that 
the concentration and the chemical nature 
of the compounds, rather than their dose, 
have a significant influence on the overall 
effect33. Compared to Pb poisoning, Sn 
poisoning from inorganic compounds is less 
documented, but it has been established that 
the short-term effects include ataxia, muscle 
weakness and irritation of gastrointestinal 
mucosa that might lead to vomiting and 
diarrhoea7,23–25 [Au:OK?]. Upon chronic 
exposure, effects similar to Pb exposure are 
expected, such as mineral imbalance and 
renal and hepatic dysfunction7,23–25. Effects 
on the reproductive and neuronal system, 
and the possibility of genotoxicity and 
carcinogenicity are still under debate7.
If inadvertent Pb or Sn intoxication would 
occur, treatment is possible. The cornerstone 
of metal toxicity management is naturally 
the termination of exposure, but in severe 
cases therapy in the form of chelation — 
administration of chemical agents, such as 
dimercaptosuccinic acid, that bind to and 
remove heavy metals from the body — 
can be initiated. Public health actions are 
typically initiated at 5 μg/dl31. Medical 
treatment is advised starting from values of 
45μg/dl31. Due to the low occurrence of Sn 
poisoning originating from inorganic Sn 
compounds, no such directive is in place.
Assessing the perovskite life cycle
Several life cycle assessments (LCAs) and 
similar studies on perovskite solar technology 
have been reported34–37. The intention 
of an LCA is to evaluate environmental 
impacts and energy balance in every stage 
of a product’s life. Typically, five stages are 
considered: (1) raw material extraction, (2) 
synthesis of starting products, (3) fabrication, 
(4) use and (5) decommissioning. Inventories 
that contain relevant properties of all 
involved components are assembled and 
fed into specialized software that quantifies 
environmental impacts by returning scores 
in terms of so-called impact indicators. 
It should be noticed that, although such 
studies are commonly used to investigate 
the environmental justifiability of a new 
technology, their outcome may differ 
significantly, depending on the emphasis 
given to each stage of the life cycle 
and, probably, on the employed impact 
indicator34–37. Within the available studies, 
specific toxicity aspects related to the heavy 
metals used in hybrid perovskites have not 
been exhaustively discussed. We provide 
here a very concise and, above all, qualitative 
assessment of the toxicity of the perovskite 
layer in solar cells, following the typical 
stages of an LCA. As the starting products 
for perovskite solar cells are chemicals that 
are already being used on an industrial 
scale for other applications, we assume that 
the corresponding material extraction and 
synthesis have already been optimized in 
terms of health and safety, and focus therefore 
exclusively on stages three to five of the life 
cycle (as concisely summarized in Fig. 2).
Fabrication. The main sources of 
intoxication hazard during the fabrication 
of OHP layers are related to the starting 
compounds and solvents (if required in the 
synthesis procedure adopted) used. The 
chemical nature of a compound — be it 
organic or inorganic — can have a major 
influence on the bioavailability and rate 
of uptake, as follows from the correlation 
with its solubility in fat and water (which is 
a proxy for how easily it can be absorbed). 
Consequently, the overall burden of 
organolead and organotin compounds is 
considered much higher compared to their 
inorganic counterparts as they can readily 
pass biological barriers to reach vital areas 
due to their relatively high fat solubility. 
As indicated in Fig. 1 (for the Pb case), the 
general absorption is significantly higher, 
especially via the dermal and respiratory 
routes26,38. The commonly used sources of 
heavy metal intoxication upon preparation 
(and to some extent degradation) of Pb- 
and Sn-based perovskites can be ordered 
in terms of water solubility as: SnBr2 > 
SnCl2 > Pb(NO3)2 > Pb(CH3COO)2 > 
Pb(OH)2 > PbCl2 > PbBr2 > PbI2 > SnI4 
> SnI2 > SnO2 (no data are available for 
Toxicity of metal salts for precursors influenced by solubility in water and fat 
dermal and oral uptake exacerbated by solvent DMSO increases cell membrane permeability.
Not only heavy metal
intoxication severe additional
environmental burden for Sn
perovskite in the form of
acidification upon degradation
Hazardous fumes
possible in case of fire
100% reliable
encapsulation
Perovskite-dedicated protocols in labs and production facilities
Established procedures,
already optimised for
use on an industrial scale
Not global but local problem
accumulation of heavy metal







Same hazards as during the fabrication stage
Direct recuperation from old modules to starting products
Perovskite-dedicated protocols in recycling facilitiesRaw material extraction
Figure 2 | Concise schematic of the life cycle of perovskite solar cells, indicating the most important 
hazards (red) and strategies for their control (green). Safety protocols for phases one and two have 
already been established and are not described here [Au: changes have been made to the caption and 
figure by the editor. Please check and confirm whether these are ok.] .
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Pb(OH)I and SnCl4). All of these are at best 
sparingly [Au minimally?] soluble in fat, 
with the exception of Pb(CH3COO)2 which 
is soluble in both water and fat, and can 
thus be considered particularly hazardous. 
Additionally, intoxication by these 
chemicals can be significantly exacerbated 
by the presence of the commonly used 
solvents dimethylformamide (DMF) and 
dimethylsulfoxide (DMSO). Not only 
are these solvents toxic themselves (in 
particular DMF), but both are also miscible 
with water in all ratios, thus increasing the 
bioavailability and the risk of absorption 
by oral ingestion and via dermal contact. 
The hazard is even more pronounced in the 
case of DMSO, as this solvent increases the 
cell membrane permeability39. Considering 
the above, sufficient protection in the form 
of gloves (minimum 15 mil latex), dust 
masks and glasses, as well as safe storage of 
waste products, represent good laboratory 
practice, which is critical to guarantee a safe 
lab or production environment. Despite 
being very advisable, so far perovskite-
dedicated measures are generally not 
imposed in research labs, in particular where 
different research lines run concurrently. 
In large-scale production facilities, many 
processes can of course be automated and 
shielded, reducing the workers’ immediate 
proximity to the toxicants.
Use. During their useful lifetime (stage four), 
the structural integrity of perovskite modules 
placed in uncontrolled conditions (such as 
on a rooftop) can be affected, which poses 
an immediate danger related to perovskite 
degradation and leakage of toxic chemicals 
into the immediate surroundings. Perovskite 
degradation generally entails the reversion 
to its starting products, which then can 
decompose further. For the current typical 
perovskite solar cells, this would result in 
the production of PbI2 (or PbBr2), a small 
amount of metallic Pb and carbonated 
moieties that ultimately convert into 
hydroiodic acid (HI) and methylamine11. 
In the case of Sn-based perovskites, so far 
SnI2 and SnI4 have been identified8. Despite 
recent estimations pointing out that the 
annual amount of spilled Pb from defective 
perovskite solar cells would be orders of 
magnitude smaller than that from emissions 
by other energy-related activities, a more 
careful toxicological investigation is highly 
preferable because of the danger related to 
local toxicant accumulation40 [Au:OK?]. 
In a simplified stationary picture, it has 
been argued that the Pb species released 
during the degradation of perovskite by 
rain would strongly adsorb on soil particles 
and thereby remain concentrated in the 
top few centimetres (inducing a higher Pb 
concentration but also facilitating removal)14. 
Yet, this mechanism highly depends on soil 
composition and acidity41; thus, since an 
acidifier (HI) is also released upon perovskite 
degradation8, the assumption that soil may be 
able to immobilize Pb should be approached 
with great circumspection. In a worst-case 
scenario, the degradation products could 
be transported by soil water and eventually 
accumulate in unpredictable locations, and 
the concurrent increase of the environmental 
acidity may facilitate further dissolution of 
the deposited metal ions and halides42. Using 
zebrafish as a model organism, and following 
the guidelines from the Organisation for 
Economic Co-operation and Development 
(OECD) for the testing of chemicals, we 
have established that in the case of Sn 
perovskites, acidification is the decisive factor 
of toxicity (see Fig. 3a). The transformation 
of SnI2 into insoluble oxides largely nullifies 
direct Sn exposure to the organism, but 
generates HI as a by-product that, in terms 
of overall lethality, makes Sn-containing 
perovskites more acutely toxic than Pb-
containing perovskites. Yet, Pb compounds 
also caused multiple morphological 
defects in the zebrafish embryos, such as 
brain haemovascular defects and heart 
oedema (indicated in Fig. 3b). As the 
zebrafish genome shows overlap with 70% 
of protein-coding human genes and 85% 
of genes associated with human disease, 
these results also represent a first indication 
regarding the possible implications of human 
exposure43. Nevertheless, studies on higher 
model organisms are necessary to reach 
a more precise consensus on the effect of 
these heavy-metal compounds on humans, 
expanding upon the basic knowledge 
outlined in the section ‘Kinetics of Pb and Sn 
intoxication’. Lastly, a potentially exacerbating 
factor in module failure is fire, with the 
emission of toxic fumes. The inherent danger 
of such airborne toxicants is especially high 
because they can spread extremely quickly 
and are easily absorbed via inhalation. 
Therefore, a thorough investigation on the 
potential for liberating Pb or Sn, as well as 
the corresponding heavy-metal-containing 
fumes, in the event of fire is indispensable for 
the success of perovskite technology.
Decommissioning. According to the 
International Lead Association, Pb is one of 
the most effectively recycled materials in the 
world. 80% of modern Pb usage goes into the 
production of batteries, which are recycled 
according to well-established procedures. It 
has recently been demonstrated that waste 
Pb from batteries can be recycled to produce 
PbI2 with high purity for use in perovskite 
solar cells44. At the end of their useful life, 
PbI2 can be recuperated directly from the 
solar cells by using an appropriate solvent, 
purified and reused for the same purpose. 
As the same hazards apply here as in the 
fabrication stage, similar precautions are 
required. Such recycling programmes could 
be hosted by the companies themselves that 
commercialize perovskite photovoltaics, 
but the activity could also be supported by 
companies that have specific expertise in 
dealing with heavy-metal waste. In any case, 
these recycling programmes should be at 
least as environmentally friendly and cost-
effective as those for existing technologies 
(in the order of US$0.04 W–1 (CdTe) to 
US$0.13 W–1 (Si) or lower)45 [Au: please 
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Figure 3 | Exposure to SnI2 is much more acutely toxic to zebrafish than exposure to PbI2, which correlates 
directly with the pH of the growth medium8. a, The survival of zebrafish 4 days post-fertilization as a 
function of toxicant concentration and pH. b, Healthy zebrafish (control). c, Zebrafish exposed to PbI2 
(1.08∙10–2 mM), showing a brain haemovascular defect, heart oedema and dorsal curvature. d, Zebrafish 
embryo exposed to SnI2 (1.62∙10–1 mM) showing failed hatching at 96 hours post-fertilization. Images 
adapted from ref. 8, NPG.
NATURE MATERIALS | VOL 15 | MARCH 2016 | www.nature.com/naturematerials 5
commentary
Prevention through encapsulation
Considering the intoxication hazard 
inherent to the current OHPs, effective 
precautionary measures against the liberation 
of Pb compounds from a perovskite module 
are imperative. Fortunately, the common 
encapsulation layers used to safeguard a solar 
module from water and moisture also work in 
the opposite direction, preventing the module 
contents to spill into the environment. The 
typical (tempered) glass–glass encapsulation 
with ethyl vinyl acetate encapsulant (or 
similar) and polyisobutylene edge seal (or 
similar), already used in commercialized 
photovoltaic technologies, is likely to also 
prove effective for perovskite solar cells. 
Even if such encapsulated perovskite 
modules were to be damaged beyond their 
breaking point (for instance by hail or during 
an earthquake), the tough and resilient 
encapsulant would still encompass the active 
layer and would provide initial protection 
until they could be removed by a specialist. 
In addition, in case the encapsulation were 
to become locally defective, a simple built-
in electronic test would quickly reveal 
degradation before it could cause harm by 
leakage. Nevertheless, further protection 
could be offered, for example by an additional 
‘monolithic’ encapsulation, such as alumina, 
grown directly on top of the device stack 
(by atomic layer deposition)46. Alternatively, 
self-healing materials may be considered 
(with the boundary condition of sufficient 
transparency) in a standalone configuration 
or complementary to conventional 
encapsulation47. Such materials spontaneously 
restore damage upon cracking or ballistic 
puncture, helping to keep possible toxicants 
contained. As an auxiliary safeguard, a 
sufficient density of heavy-metal-capturing 
molecules could be incorporated into the 
module to confine these toxicants to an 
even greater extent48. Sulfides that react 
with the perovskites’ degradation products 
to form insoluble (thus inert) compounds 
offer another viable approach14. Similarly, to 
counteract the acidification that follows from 
HI formation during perovskite degradation, 
limestone powder can be incorporated into 
the module. However, the actual efficacy 
of these strategies needs to be verified by 
rigorous experimentation, and the cost-
effectiveness of more advanced encapsulation 
on a module level also needs to be evaluated.
Conclusions and outlook
Based on the currently incomplete 
knowledge of the toxicology of OHPs, there 
is one strict condition on which the large-
scale implementation of this photovoltaic 
technology hinges: 100% reliable containment 
of degradation products from modules that 
lose their structural integrity during their 
useful life. The perovskite technology can 
be deployed in a completely safe way (both 
for human health and the environment) 
only if modules are fitted with an absolutely 
fail-safe encapsulation, resistant to extreme 
conditions. At the same time, LCAs need to 
be expanded by incorporating the possibility 
of module failure to accurately map the full 
environmental impact of OHPs in a worst-
case scenario. Standardized protocols for 
module recycling should also be established. 
Furthermore, given the limited knowledge 
on the toxicity of the various Pb and Sn 
compounds and the read-across issue, more 
in-depth investigation is becoming very 
relevant in that area as well.
Pb has been playing a major role in 
perovskite solar cells, leading to remarkable 
advances in terms of efficiency and, to some 
extent, stability49. It is thus conceivable that 
Pb-based OHP technology will be the first to 
enter the market, on the strict condition of 
fail-safe encapsulation. In parallel, arguably 
the advances with the greatest impact could 
arise from anion and cation exchange in the 
perovskite crystal by suitable stable alternatives. 
Herein, Pb or Sn could either still be present 
in a more rigid perovskite matrix, or replaced 
by another (preferably non-toxic) metal, such 
as Bi50. In any case, the challenge then lies in 
the retention of favourable properties in terms 
of bandgap, absorption coefficient, charge 
transport and ease of processing. As such, 
future avenues of perovskite research to achieve 
intrinsic environmental friendliness will 
undoubtedly stem from the interplay between 
theoretical simulations and experimental 
discoveries [Au:OK?].
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